Mary Pinder-Schenck

Overall Survival and Long-Term Safety of Nivolumab (Anti–Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer

Scott Gettinger, Leora Horn, Leena Gandhi et al. · Journal of Clinical Oncology · 2015 · 1.2K citations · Full text

Medicine, Oncology, Pharmacology +17

Non–Small Cell Lung Cancer, Version 2.2013

David S. Ettinger, Wallace Akerley, Hossein Borghaei et al. · Journal of the National Comprehensive Cancer Network · 2013 · 452 citations

Medicine, Oncology, Cancer Screening +7

Non–Small Cell Lung Cancer

David S. Ettinger, Wallace Akerley, Hossein Borghaei et al. · Journal of the National Comprehensive Cancer Network · 2012 · 362 citations · Full text

Medicine, Oncology, Surgery +17

Randomized International Phase III Trial of ERCC1 and RRM1 Expression–Based Chemotherapy Versus Gemcitabine/Carboplatin in Advanced Non–Small-Cell Lung Cancer

Gerold Bepler, Charles C. Williams, Michael J. Schell et al. · Journal of Clinical Oncology · 2013 · 143 citations · Full text

Medicine, Oncology, Pharmacology +13

Thymomas and Thymic Carcinomas

David S. Ettinger, Gregory J. Riely, Wallace Akerley et al. · Journal of the National Comprehensive Cancer Network · 2013 · 124 citations · Full text

Medicine, Oncology, Surgery +15